Beam Therapeutics Inc.

United States of America


 
Total IP 210
Total IP Rank # 6,123
IP Activity Score 3.1/5.0    237
IP Activity Rank # 2,949
Stock Symbol BEAM (nasdaq)
ISIN US07373V1052
Market Cap. 2,200M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

67 4
52 0
83 4
0
 
Last Patent 2025 - Novel rna base editing compositi...
First Patent 2018 - Uses of adenosine base editors
Last Trademark 2023 - BEAM THERAPEUTICS
First Trademark 2019 - BEAM THERAPEUTICS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Novel rna base editing compositions, systems, methods and uses thereof. The present invention pr...
Invention Anti-idiotypic antibodies to cluster of differentiation 7-targeted binding domains and related co...
Invention Nanomaterials comprising tetravalent lipid compounds. The present disclosure describes compositi...
Invention Nanomaterials comprising diamines. The present disclosure describes compositions, preparations, ...
Invention Ionizable amine and ester lipids and lipid nanoparticles. The present disclosure describes compo...
Invention Ionizable amine lipids and lipid nanoparticles. The present disclosure describes compositions, p...
Invention Nanomaterials comprising disulfides. The present disclosure describes compositions, preparations...
Invention Methods and compositions for treating alpha-1 antitrypsin deficiency. Compositions and methods fo...
Invention Compositions and methods for the treatment of spinal muscular atrophy (sma). The invention of th...
Invention Crispr enzymes, methods, systems and uses thereof. The present invention provides novel systems,...
Invention Modified immune cells and methods of using the same. The present invention features modified imm...
Invention Methods and compositions for anti-cd45 based non-genotoxic conditioning. The disclosure compositi...
Invention Compositions and methods for the treatment of hereditary angioedema (hae). The invention of the ...
Invention Compositions and methods for treating stargardt disease. ABCA4ABCA4ABCA4 gene so that the nucleot...
Invention Modified guide rna. The present invention relates to modified gRNA molecules, compositions and me...
Invention Genetic modification of hepatocytes. The present invention provides methods of producing genetic...
Invention Compositions and methods for treating hepatitis b virus infection. The invention features compos...
Invention Immunosuppressant-resistant modified allogeneic modified immune cells and methods for use thereof...
Invention Nanomaterials comprising triols. The present disclosure describes compositions, preparations, na...
Invention Modified immune effector cells with improved efficacy. Multiplex base edited chimeric antigen rec...
Invention Persistent allogeneic modified immune cells and methods of use thereof. The present disclosure f...
Invention Chimeric pseudotyped recombinant rabies virus. Provided herein are chimeric pseudotyped recombin...
Invention Chimeric pseudotyped recombinant rabies virus. Provided herein are chimeric pseudotyped recombina...
Invention Guide rnas for crispr/cas editing systems. The present invention provides, among other things, a...
2023 Invention Circular guide rnas for crispr/cas editing systems. The present invention provides, among other ...
Invention Compositions and methods for the self-inactivation of base editors. The invention features polyn...
Invention Compositions and methods for editing a transthyretin gene. Compositions for gene modification rel...
Invention Base editing of transthyretin gene. Provided herein are compositions for gene modification relat...
Invention Compositions and methods for treating transthyretin amyloidosis. The invention features composit...
Invention Base editing of transthyretin gene. Provided herein are compositions for gene modification relate...
Invention Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target seq...
G/S Pharmaceutical and biological preparations based on base editing, base modification, nucleobase e...
Invention Adenosine deaminase variants and uses thereof. The invention provides adenosine deaminase varian...
Invention Synthetic polypeptides and uses thereof. Provided herein are synthetic polypeptides including tra...
Invention Large serine recombinases, systems and uses thereof. The present invention provides novel serine ...
Invention One vector system for identification of genome modifying enzymes. The present application relates...
Invention Uses of adenosine base editors. The disclosure provides methods and compositions for treating bl...
Invention Modified allogeneic cells and methods and compositions for the preparation thereof. e.g.e.g., T- ...
Invention Compositions and methods for treating a congenital eye disease. CEP290CEP290CEP290CEP290CEP290 ge...
Invention Nanomaterials comprising triols. The present disclosure describes compositions, preparations, nan...
Invention Nanomaterials comprising an ionizable lipid. The present disclosure describes compositions, prep...
Invention Ionizable lipids for nanomaterials. The present disclosure describes compositions, preparations,...
Invention Adenosine deaminase base editors and methods for use thereof. Adenosine deaminase base editors, c...
Invention Compositions and methods for non-genotoxic cell conditioning. Compositions and methods for non-ge...
Invention Nanomaterials comprising carbonates. The present disclosure describes compositions, preparations...
Invention Nanomaterials comprising ester-linked acetals. The present disclosure describes compositions, pr...
Invention Compositions and methods for reducing complement activation. Compositions and methods for reducin...
Invention Modified regulatory t cells and methods of using the same. REGe.g.CONVCONV) cells), and/or increa...
Invention Identification of nanoparticles for preferential tissue or cell targeting. in vivoin vivo screeni...
2022 Invention Novel crispr enzymes, methods, systems and uses thereof. The present invention provides novel sy...
2021 Invention Compositions and methods for treating glycogen storage disease type 1a. Described and provided a...
2019 G/S Pharmaceutical and biological preparations based on base correction, base editing, base modifica...
G/S Scientific and medical research in the fields of base editing, base modification, base repair, nu...